Evidence map›Paper›PMID 28882482›Full record

ArticleBioorganic & medicinal chemistry letters2017

Ester-prodrugs of ethambutol control its antibacterial activity and provide rapid screening for mycobacterial hydrolase activity.

Erik M Larsen, Dominique C Stephens, Nathan H Clarke, R Jeremy Johnson

Open access · greenAbstract read
In one paragraph

Article in Bioorganic & medicinal chemistry letters, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Metabolic Rewiring ofMetabolites · 2024
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Erik M LarsenDepartment of Chemistry and Biochemistry, Butler University, 4600 Sunset Ave., Indianapolis, IN 46208, USA.
Dominique C StephensDepartment of Chemistry and Biochemistry, Butler University, 4600 Sunset Ave., Indianapolis, IN 46208, USA.
Nathan H ClarkeDepartment of Chemistry and Biochemistry, Butler University, 4600 Sunset Ave., Indianapolis, IN 46208, USA.
R Jeremy JohnsonDepartment of Chemistry and Biochemistry, Butler University, 4600 Sunset Ave., Indianapolis, IN 46208, USA. Electronic address: rjjohns1@butler.edu.
Butler University · US

Funding

Investigation of mycobacterial hydrolases and their role in lipolysis.R15GM110641 · NIGMS · BUTLER UNIVERSITY · PI JOHNSON, RANDAL JEREMY · 2015 to 2015
$306k
NIGMS NIH HHS R15 GM110641
6 · The paper itself

Abstract

M. tuberculosis contains an unusually high number of serine hydrolases by proteome percentage compared to other common bacteria or humans. This letter describes a method to probe the global substrate specificity of mycobacterial serine hydrolases with ester-protected prodrugs of ethambutol, a first-line antibiotic treatment for TB. These compounds were synthesized directly from ethambutol using a selective o-acylation to yield products in high yield and purity with minimal workup. A library of derivatives was screened against M. smegmatis, a non-infectious model for M. tuberculosis, which displayed significantly lowered biological activity compared to ethambutol. Incubation with a general serine hydrolase reactivated each derivative to near-ethambutol levels, demonstrating that esterification of ethambutol should provide a simple screen for mycobacterial hydrolase activity.

Indexed as

Anti-Bacterial AgentsDose-Response Relationship, DrugDrug Evaluation, PreclinicalEnzyme InhibitorsEstersEthambutolHydrolasesMicrobial Sensitivity TestsMolecular StructureMycobacterium smegmatisMycobacterium tuberculosisProdrugsStructure-Activity RelationshipAnti-Bacterial AgentsEnzyme InhibitorsEstersEthambutolHydrolasesProdrugsAntibioticsEthambutolHydrolasesM. tuberculosisProdrugsTuberculosis

Identifiers

PMID28882482
PMCPMC5607105
OpenAlexW2752877671

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.